Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by BioTeckon Jan 10, 2023 12:48pm
380 Views
Post# 35213719

RE:RE:quick question

RE:RE:quick question
Slowly but surely. Better than the alternative.
 
 
The problem with some sernova shareholders is they are becoming extremely presumptuous. They think they are sitting on a diabetes cure but don't understand that along the way any of the many steps involved have a higher chance of failure than success. Each time we are presented with a success it is taken for granted. Remember the cure for diabetes is always 5 years away.
 
 
"T1D preclinical models with iPSC derived islet clusters transplanted in Sernova’s Cell Pouch has now demonstrated consistent long-term insulin independence de-risking the combined technologies for both companies."
 
 
Maybe think of what would have happened if the preclinicals didn't go well and the evotec cells didn't show consistent and long term insulin independence in the cell pouch. We would all be standing with our pouches in our hands. This is a risky play not a sure bet cure for diabetes. There is a reason we are trading where we are. 
 
 
Looking forward to the AGM where we will certainly lose some dead weight this year. Barney and Selphie need to stop glorifying events like JPM. We all know that is not where people go to sign deals. It's like going to the AVN conference thinking you're going to bring home the hottest star. 
 
 
The only thing spill is getting at JPM is a 5 dollar, make you Holler moustache ride.  He should be focusing his efforts on building liquidity and getting the complainers who want out and institutional investors in. If he can't drum up any interest at these rock bottom prices, perhaps he isn't the man for the job. 
 
<< Previous
Bullboard Posts
Next >>